Codexis (LTS:0I0X) Inventories, Finished Goods : $2.30 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Codexis Inventories, Finished Goods?

Codexis's quarterly finished goods increased from Sep. 2023 ($2.20 Mil) to Dec. 2023 ($2.57 Mil) but then declined from Dec. 2023 ($2.57 Mil) to Mar. 2024 ($2.30 Mil).

Codexis's annual finished goods increased from Dec. 2021 ($1.05 Mil) to Dec. 2022 ($1.83 Mil) and increased from Dec. 2022 ($1.83 Mil) to Dec. 2023 ($2.57 Mil).

Codexis Inventories, Finished Goods Historical Data

The historical data trend for Codexis's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Codexis Inventories, Finished Goods Chart

Codexis Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

0.34

0.81

1.05

1.83

2.57

Codexis Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Inventories, Finished Goods	Get a 7-Day Free Trial															1.85	1.94	2.20	2.57	2.30

Codexis Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Codexis (LTS:0I0X) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Codexis Inc (LTS:0I0X) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

CDXS:USA 4QK:Germany

Address

200 Penobscot Drive, Redwood, CA, USA, 94063

Website

https://www.codexis.com

Codexis Inc is involved in the business of providing enzyme optimization services, commercialization of proteins, and developing biocatalyst products. The firm's products and services include Screening and Evolution services, Enzymes, Screening Kits. It also develops protein engineering and biocatalyst platforms such as Codeevolver, Ketoreductases, Transminases, Imine reductases, etc. The company operates in two business segments namely Performance Enzymes and Novel Biotherapeutics. It generates maximum revenue from the Performance Enzymes segment. Geographically, it derives a majority of revenue from the APAC.

Codexis (LTS:0I0X) Headlines

No Headlines